By being vertically integrated and owning all steps of the pharmaceutical development and production process, Accord can bring high quality medicines to patients faster, more economically and with greater efficiency than our rivals.
Accord has one of the most dynamic product pipelines in the pharmaceutical industry. Already we boast a portfolio of over 130 molecules across multiple therapeutic classes. We are committed to build up this number to compete with the largest product ranges in the sector. To date, we have gained nearly 7,000 marketing authorizations across the European Economic Area.
Accord has a particular focus on encouraging the safe use of our products, both for patients and medical professionals